<DOC>
	<DOCNO>NCT02221531</DOCNO>
	<brief_summary>Postpartum haemorrhage ( PPH ) obstetric emergency define blood loss ≥500ml vaginal birth ≥1000ml caesarean section ( CS ) and/or need blood transfusion within 24 hour delivery ( World Health Organization , Recommendations Prevention Postpartum Haemorrhage . 2007 ; Leduc et al. , J Obstet Gynaecol Can , 2009 ) . Since PPH common caesarean delivery vaginal birth rate CS rising time probably continue rise , incidence PPH expect increase accordingly . A meta-analysis show routine administration oxytocic agent caesarean delivery lead reduce blood loss decrease risk PPH ( Cotter et al. , Cochrane Database Syst Rev , 2001 ) . The two commonly use oxytocic drug operative delivery oxytocin carbetocin , synthetic oxytocin-analogue . Carbetocin advantage oxytocin longer half-life therefore reduce use additional uterotonics . Based finding reduce cardiovascular side-effects short-infusion compare bolus injection find oxytocin ( Thomas et al. , Br J Anaesth , 2007 ) , study hypothesis slow administration rate carbetocin minimise cardiovascular side effect without compromise uterine tone . Therefore , aim investigate short infusion carbetocin 100 mcg apply 100ml sodium chlorid compare bolus application woman undergo primary secondary caesarean delivery . This prospective , double-blind , randomise control non-inferiority trial take place University Hospital Basel , Switzerland . We hypothesize uterine contraction inferior ( primary efficacy endpoint ) mean arterial pressure high short-infusion bolus administration ( primary safety endpoint ) .</brief_summary>
	<brief_title>Carbetocin Trial : Carbetocin Appropriate Rate Better Equilibrium Between Tonus ( TOnus ) CIrculatioN</brief_title>
	<detailed_description />
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>healthy woman singleton pregnancy caesarean section regional anaesthesia old 18 year write informed consent emergency caesarean section secondary caesarean section due fetal distress comorbidities ( cardiovascular , kidney liver disorder , epilepsy ) obstetric disease ( hypertension , ( pre ) eclampsia ) uterine malformation ( include uterine fibroid ) bleed disorder know hypersensitivity carbetocin oxytocin fetal malformation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>